Compare ERIC & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ERIC | STE |
|---|---|---|
| Founded | 1876 | 1985 |
| Country | Sweden | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.1B | 25.9B |
| IPO Year | N/A | 1992 |
| Metric | ERIC | STE |
|---|---|---|
| Price | $9.62 | $251.72 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 9 |
| Target Price | $9.80 | ★ $268.25 |
| AVG Volume (30 Days) | ★ 8.6M | 630.8K |
| Earning Date | 01-23-2026 | 02-04-2026 |
| Dividend Yield | ★ 2.04% | 1.00% |
| EPS Growth | N/A | ★ 59.39 |
| EPS | 0.78 | ★ 6.97 |
| Revenue | ★ $25,502,929,121.00 | $5,702,415,000.00 |
| Revenue This Year | N/A | $9.61 |
| Revenue Next Year | N/A | $6.23 |
| P/E Ratio | ★ $12.30 | $36.10 |
| Revenue Growth | N/A | ★ 7.08 |
| 52 Week Low | $6.64 | $200.98 |
| 52 Week High | $10.35 | $268.60 |
| Indicator | ERIC | STE |
|---|---|---|
| Relative Strength Index (RSI) | 52.51 | 42.47 |
| Support Level | $9.54 | $250.46 |
| Resistance Level | $9.68 | $255.31 |
| Average True Range (ATR) | 0.12 | 4.78 |
| MACD | -0.01 | -1.63 |
| Stochastic Oscillator | 40.32 | 10.58 |
Ericsson provides telecom equipment and services that are primarily used to build and operate mobile networks. The firm divides its business into three segments: networks, cloud and software services, and enterprise. Wireless carriers have traditionally been the firm's primary customers, but it is pushing to cater more to enterprises as well, as both try to take advantage of 5G capabilities and utilize "as-a-service" communications platforms. The company also licenses its patents to handset manufacturers.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.